Email not displaying correctly?  View it in your browser.
Volume 6, Issue 3, September 2017

Director's message: Reducing the burden of cancer
Mayo Clinic researchers are advancing new ways to help reduce side effects of cancer treatment.
Shorter duration chemo for low-risk stage III colon cancer
Reducing the length of adjuvant therapy with oxaliplatin is effective and reduces toxicity.
Nonmelanoma skin cancers on the rise
An increase in basal cell carcinoma and squamous cell carcinoma renews the call for caution in tanning.
Genetic test accurately detects early pancreatic cancer
Biomarkers can potentially change the paradigm of clinical practice in patients with pancreatic cysts.
List of breast cancer genes clarified
The results will help identify members of families who are at increased risk of breast cancer.
Researchers ID protein interaction behind metastasis
Their work shows that there's a direct interaction between focal adhesion kinase and myosin.
New print edition of Forefront
Read about cancer detection, multiple myeloma, colon cancer, a glioblastoma vaccine and more.
Meet the Investigator: Andrea E. Wahner Hendrickson, M.D.
Dr. Wahner Hendrickson discusses ovarian cancer treatment, translational research and clinical trials.
We're interested in your feedback about this email.

Want the Print Edition?
A print edition of Forefront is published annually. To request a free subscription, send your name and mailing address to
Mayo Clinic Cancer Center
13400 E. Shea Blvd.
Scottsdale, AZ 85259

4500 San Pablo Road
Jacksonville, FL 32224

200 First Street SW
Rochester, MN 55905